EQUIFLOW Trademark

Trademark Overview

On Monday, December 13, 2021, a trademark application was filed for EQUIFLOW with the United States Patent and Trademark Office. The USPTO has given the EQUIFLOW trademark a serial number of 97169280. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, October 15, 2024. This trademark is owned by ReCellerate, Inc.. The EQUIFLOW trademark is filed in the Pharmaceutical Products category with the following description:

Stem cell therapeutic preparations for veterinary purposes; stem cell therapeutic preparations for medical purposes; therapeutic preparations for the treatment of exercise induced pulmonary hemorrhage (EIPH)
equiflow

General Information

Serial Number97169280
Word MarkEQUIFLOW
Filing DateMonday, December 13, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2023

Trademark Statements

Goods and ServicesStem cell therapeutic preparations for veterinary purposes; stem cell therapeutic preparations for medical purposes; therapeutic preparations for the treatment of exercise induced pulmonary hemorrhage (EIPH)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 16, 2021
Primary Code005
First Use Anywhere DateMonday, October 31, 2016
First Use In Commerce DateMonday, October 31, 2016

Trademark Owner History

Party NameReCellerate, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20024
Party NameReCellerate, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSterling, VA 20165

Trademark Events

Event DateEvent Description
Wednesday, September 21, 2022NON-FINAL ACTION WRITTEN
Thursday, December 16, 2021NEW APPLICATION ENTERED
Thursday, December 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Wednesday, September 21, 2022NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 2, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 2, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 15, 2023SOU EXTENSION 1 FILED
Friday, December 15, 2023SOU EXTENSION 1 GRANTED
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU EXTENSION 2 FILED
Friday, June 28, 2024SOU EXTENSION 2 GRANTED
Monday, July 15, 2024TEAS STATEMENT OF USE RECEIVED
Monday, July 22, 2024USE AMENDMENT FILED
Monday, July 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 15, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 15, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

equiflow therapeutic preparations cell stem purposes pulmonary hemorrhage eiph induced medical